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Abstract
Th17 cells are pro-inflammatory CD4+T cells, which are important in immune responses against fungal pathogens and
extracellular bacteria and have also been implicated in various autoimmune syndromes. However, their role in supporting B
cell responses in these scenarios remains unclear, representing a significant lapse in our understanding of the role Th17 play
in vaccine responses and the regulation of autoimmunity. We employed T cell and B cell receptor transgenic mice specific
for model antigens, and adoptive transfer approaches that allowed the tracking of cognate B and T cells in situ and ex vivo
using immunological methods. We have found that T cells activated under Th17 polarising conditions have a greater
capacity to provide cognate B cell help compared with Th1 polarised populations, supporting higher expansion of antigen
specific B cells and enhanced antibody titres. This advantage is associated with the increased persistence of Th17 polarised
cells in areas of the lymph nodes where they can provide help (i.e. the B cell follicles). Also the Th17 cells are characterised
by their higher expression of ICOS, a costimulatory molecule important for B cell help. Surprisingly, contrary to published
reports, Th17 cells were not detected inside germinal centres, although they were found in close proximity to cognate B
cells in the follicle early in the genesis of the humoral immune response. These data indicate that, Th17 cells have a more
significant role earlier in the initiation/development of the germinal centre response and/or germinal centre-independent
events, consistent with their early effector status.
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Introduction
Th17 T cells are pro-inflammatory cells that produce cytokines
such as IL-17A, IL-17F, IL-21 and IL-22 and are identified by the
lineage transcription factor RORct [1]. Both human and animal
studies have demonstrated an important role for Th17 cells in
mucosal and epithelial defence, especially against fungi and
extracellular bacteria [1,2]. Due to the production of cytokines
such as IL-17 and IL-22, Th17 have been linked to various
inflammatory syndromes namely psoriasis and Crohn’s disease [3].
Their role as effector cells has generally been investigated in the
tissue site where they induce events such as neutrophil accumu-
lation and production of antimicrobial peptides [1,4,5]. On the
other hand, their function in the lymph node (LN), and specifically
their ability to provide help to B cells, has not been analysed to the
same extent. This is important as in several protective or
pathogenic conditions Th17 cells appear to be involved in
scenarios where antibodies play an important role [1].
During the development of a T cell-dependent antibody
response, several distinct T-B cognate interactions take place in
the secondary lymphoid organs [6]. These events are co-ordinated,
take place in defined areas of secondary lymphoid organs and can
result in the generation of either early memory B cells, germinal
centre (GC) B cells or extra-follicular plasma cells [6]. It has been
proposed that the T cells providing B cell help constitute a distinct
Th subset, termed T follicular helper (TFH) [7]_ENREF_4. These
cells are characterised by the high expression of the chemokine
receptor CXCR5, co-stimulatory molecules such as ICOS and
PD-1, the cytokine IL-21 and the transcription factor Bcl-6 [7].
However, there is also evidence to indicate that effector cells can
also support B cell responses. Firstly, most activated CD4+cells up-
regulate CXCR5 transiently, regardless of the immune response
elicited [8]. In addition, we have previously demonstrated that
in vitro and in vivo generated Th1 and Th2 cells can migrate to the
B cell follicle where they support cognate B cells [9,10], whereas
cells with a TFH phenotype have been shown to express the Th2
transcription factor GATA-3 [11]. Specifically for Th17 cells, few
studies have investigated their role in a humoral immune response
[12,13]. Studies in the BXD-2 mouse strain that develop a lupus
like syndrome, demonstrate that IL-17 promotes the formation of,
and stabilises, the developing GC. Interestingly, it has been
demonstrated that IL-17-expressing CD4+T cells can be located in
GCs in proximity to IL-17R+B cells [12]. This is controversial as
other studies suggest that, unlike cytokines such as IL-4 and IL-21,
IL-17 is not characteristic of GC T cells [14]. This might suggest
that the results in the BXD-2 mice might not represent
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a physiological process but to reflect the autoimmune background
of the strain.
In this study we attempted to investigate the role of Th17 cells in
the development of a humoral immune response, in a manner that
allowed us to track and manipulate the cognate B and T cell
populations [9,10]. Our group and others have demonstrated that
this is a good model for analysis of cell localisation during the early
phase of the B response and the GC reaction [9,10,15–17]. In
addition, we compared the relative ability of Th17 and Th1 cells
to support B cell responses, as these subsets appear to have
overlapping functions in protective immunity and have been
linked to autoimmune syndromes.
We demonstrate that cells polarised under Th17 conditions
appear to be more efficient at supporting B cell responses
compared to their Th1 counterparts, inducing higher expansion
of cognate B cells, increased levels of class switched antibodies and
greater numbers of GC B cells. There was also a difference in the
character of the antibody response, with cells polarised under
Th17 conditions promoting higher IgG1 levels whereas their Th1
counterparts supported higher IgG2c responses. We show that this
relative advantage may be related to differences in the clonal
expansion between the two populations, as cells polarised under
Th17 conditions persisted longer and in higher numbers in the
dLNs and B cell follicles, and expressed higher levels of the co-
stimulatory molecule ICOS than their Th1 counterparts. Further-
more, Th17 cells were located in close proximity to cognate B cells
at early time points in the immune response but were not found in
the GC. This suggests that these cells are not involved in the events
that take place in the GC but rather, they are crucial for the very
early, extra-germinal centre antibody response that is beneficial in
many infections.
Materials and Methods
Animals
Homozygous DO11.10 BALB/c (H-2d/d) mice, expressing the
DO11.10 T cell receptor (TcR) specific for chicken ovalbumin
(OVA) peptide 323–339/I-Ad, were used as CD4+cell donors.
Mice heterozygous for the anti-hen egg lysozyme (HEL) IgMa and
IgDa transgenes on the BALB/c background (MD4) were screened
by flow cytomentry and animals positive animals were used as
donors of transgenic B cells [18]. IgHb BALB/c (H-2d/d, IgMb)
mice [19] were used as recipients of the transgenic B cells. All
procedures were carried out according to UK Home Office
regulations, under UK Home Office Project Licence PPL/
603658, and approved by the Glasgow University animal use
committee.
T Cell Purification and Polarisations and Cell Culture
CD4+T cells were purified from pooled LNs and spleens from
DO11.10 mice by negative selection (Miltenyi Biotec, Surrey,
UK). Positive fractions were treated with mitomycin C (Sigma-
Aldrich, Irvine, UK) and used as APCs. Th1 differentiation was
induced by culturing CD4+cells with mitomycin C treated
splenocytes as antigen presenting cells (APCs) in the presence of
anti-IL-4 antibody (2 mg/ml, R&D Systems, Abingdon, UK), IL-
12 (10 ng/ml, R&D Systems) and OVA323–339 (0.5 mg/ml,
Cambidge Bioscience, Cambridge, UK). Th17 differentiation
was induced by culturing CD4+T cells and APCs in the presence
of anti-IL-4 (10 mg/ml), anti-IFNc (10 mg/ml, BD Biosciences,
Oxford, UK), IL-6 (20 ng/ml), TGFb (1 ng/ml,), IL-23 (10 ng/
ml), IL-1b (10 ng/ml) (R&D Systems) and OVA323–339 (0.5 mg/
ml). In both Th1 and Th17 polarisation cells were cultured in
IMDM with 10%FCS, 2 mM L-glutamine, 100 U/ml penicillin
and 100 mg/ml streptomycin for 4 days, and were then harvested
for transfer. Bone marrow dendritic cells (BMDCs) were generated
from BALB/c mice in the presence of GM-CSF conditioned
medium for seven days as previously described [20]. To assess the
viability of the polarised transgenic T cells, Th1 or Th17 polarised
T cells were co-cultured with LPS activated or not BMDCs for 24
or 48 hrs in the presence or absence of OVA. Viability was
assessed using the Annexin-V FITC kit (Miltenyi Biotec).
Carboxyfluorescein succinimidyl ester (CFSE) dilution assay was
performed using CellTraceTM CFSE proliferation kit (Invitrogen)
according to manufacturer’s instructions.
Adoptive Transfers and Immunisations
Single cell suspensions of LNs and spleens were prepared from
MD4 mice as described previously5. The proportion of transgenic
B and T cells was determined by flow cytometry. 26106 transgenic
B cells and 26106 transgenic Th1 or Th17 populations were
adoptively transferred to age-matched IgHb BALB/c recipients.
One day post transfer mice were immunised with 130 mg of OVA-
HEL conjugate in CFA. Control mice were injected with PBS.
Conjugated OVA-HEL was prepared as previously described [9].
Flow Cytometry
At days 3, 7 and 10 post-challenge single cell suspensions were
produced from LNs draining the site of immunisation from
recipient mice and aliquots were stained with combinations of
anti-CD4 PercP (RM4-5, BD Biosciences), KJ1.26 FITC
(eBioscience, Hatfield, UK), biotinylated anti-CXCR5 (2G8, BD
Biosciences), anti-ICOS PE or PE-Cy5 (7E.17G9, BD Bios-
ciences), anti-B220 APC (RA3-6B2, eBioscience), anti-GL-7 FITC
(GL7), anti-FAS PE (Jo2), PD-1 PE-Cy7 (RPM1-30, Biolegend)
and biotinylated anti-IgMa(DS-1) (BD Biosciences). For intracel-
lular cytokine staining cells were stimulated with PMA (50 ng/ml)
and ionomycin (500 ng/ml) (Sigma-Aldrich) in the presence of
Golgi PlugTM (BD biosciences) for 4 hrs and stained for IFNc
APC (XMG1.2) and IL-17 PE (TC11-18H10) (BD Biosciences) as
described previously6.For nuclear staining the BD transcription
factor buffer set was used according to manufacturer’s instructions.
Anti-human/mouse RORct APC (AFKJS-9, eBioscience), anti-
Bcl-6 PE (K112-91, BD Pharmigen) and anti-Tbet PE-Cy7
conjugated antibodies (eBio4B10, eBioscience) were used to
identify transcription factor expression. Appropriate isotype
controls were used in all cases (BD Biosciences). Samples were
analysed using FlowJo (Tree Star Inc, Ashland, OR, USA).
ELISA
Anti-OVA and anti-HEL antibodies were detected by ELISA as
previously described [9]. For detection of IgG2c antibodies
a mouse anti-IgG2a antibody was used (Southern Biotech, AL,
USA) that cross-react with IgG2c.
Immunofluorescence
At days 3,7 and 10 post immunisation draining LNs were snap-
frozen in OCT embedding medium (VWR) and stored at 280uC.
8 mm sections were cut and fixed in acetone. For detecting the
transgenic T cells sections were stained with biotinylated KJ1.26
(Miltenyi Biotec) followed by steptavidin Alexa FluorH 647
(Invitrogen, Paisley, UK). For identifying RORct expressing cells,
section were stained with anti-RORct (eBioscience, AFKJS-9),
followed with anti-Rat IgG FITC (Southern Biotech, Birmingham,
Alabama, USA), rabbit anti-FITC Alexa FluorH 488 (Invitrogen),
anti-rabbit Alexa-FluorH 488 (Invitrogen). B cell follicles were
identified by either staining with anti-B220 FITC (RA3-6B2,
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eBioscience). Transgenic B cells were identified using a biotinylated
anti-IgMa (MA-69, Biolegend, Cambridge, UK) antibody as host
B cells express IgMb and streptavidin Alexa-FluorH 546 (Invitro-
gen). GCs were identified with biotinylated-peanut agglutinin and
streptavidin Brilliant Violet 421TM (Biolegend). Images were taken
using LSM510 META Confocal Imaging System (Zeiss) and were
analysed using VolocityH software (Perkin Elmer, Cambridge,
UK). The tile scan function of the microscope allowed imaging of
the full surface of the LN section. Areas of interest were drawn
around the borders of the sections or around the follicular regions.
This allowed the calculation of the surface of LN section and
follicular area respectively. In addition the number of transgenic T
cells in the section and in the follicular areas could be calculated
(Fig S1). The localisation of T cells in the follicular area was
calculated as a fraction of the proportion of KJ1.26+cells in the
follicular area (Tg T cellsfollicle/Tg T cellstotal) to the proportion of
the follicular surface (areafollicle/areatotal) (Fig S1). This gave
a number that was normalised for both T cell expansion (Tg T
cellstotal) and follicular area (areafollicle), and thus differences
observed would be due to follicular localisation and not higher
clonal expansion or larger follicular area in a specific section.
Statistics
Data were analysed using the GraphPad PrismH software. To
test if the means of two samples are different the Student’s t-test
was used. To compare the means of two or more samples ANOVA
was used. When the interaction of two independent variables was
tested two-way ANOVA was employed. A value of P,0.05 was
considered as significant.
Results
Cells Polarised Under Th17 Conditions Demonstrate
Greater Ability in Supporting B Cell Responses Compared
to Th1 Polarised Cells
To investigate the relative ability of Th1 and Th17 cells to
support B cells, an adoptive transfer approach was employed that
allowed the tracking of antigen-specific B and T cells. This is an
adaptation of a previously described model in which the response
of BCR transgenic cells depends on cognate help provided by
antigen specific transgenic T cells [9,10,15]. In brief, OVA-specific
T cells from DO11.10 mice were polarised under Th1 or Th17
polarising conditions and adoptively transferred with hen egg
lysozyme (HEL)-specific B cells from MD4 mice to IgHb congenic
recipient mice prior to HEL-OVA/CFA challenge (Fig S2A and
C).
The GC is known to be associated with T cell dependent
antibody responses and is the site where clonal selection and
expansion, class switching, somatic hypermutation and affinity
maturation occur [21]. Based on this, the ability of cells polarised
under Th1 or Th17 conditions to support the generation of GC B
cells was initially investigated. GC B cells were identified by the
expression of GL-7 and FAS by flow cytometry as done previously
by ourselves and others (Fig S3B) [22,23]. In both Th1 and Th17
recipient mice GC B cells were present at a higher percentage and
number in the draining LN (dLN) than unimmunised controls by
day 7 after immunisation (Fig. 1A and B). The number and
percentage of GC B cells was significantly higher in mice that had
received cells polarised under Th17 conditions compared to those
that had received Th1 polarised cells (Fig. 1A and B). This was
apparent both at days 7 and 10. To determine their ability to
provide B cell help, we analysed the impact of Th1 and Th17 cells
on the clonal expansion of cognate transgenic B cells, identified by
their expression of IgMa (Fig S3A). In the absence of immunisa-
tion, as anticipated, transgenic B cells did not expand in either
Th1 or Th17 recipient mice. In response to HEL-OVA/CFA,
mice that received the Th17 polarised population exhibited
significantly higher antigen specific B cell clonal expansion
compared with Th1 recipient mice (Fig. 1C and D). In both
Th1 and Th17 recipient mice, the proportion and number of
transgenic B cells was higher than in unimmunised groups (Fig. 1C
and D) and clonal expansion peaked between days 3 and 7.
However, in the case of Th17 recipients, B cell numbers had not
returned to unimmunised levels by day 10 and it is likely that their
number declines at a later time point (Fig. 1C and D). These data
indicate an enhanced and sustained ability of cells polarised under
Th17 conditions to support B cell clonal expansion compared with
their Th1 counterparts.
To determine the functional status of the transgenic B cells,
their ability to produce HEL specific antibodies was assessed by
ELISA. Serum was sampled on days 3, 7 and 10 post
immunisation and assessed for anti-HEL IgMa antibody titres. T
cells polarised under either Th1 or Th17 conditions could support
antibody production, however the Th17 population promoted
higher levels of HEL-specific antibodies compared with their Th1
counterparts, at all time-points investigated (Fig. 2A–C). In the
absence of immunisation there was no antibody production in
either Th1 or Th17 recipient mice. These results demonstrate that
cells polarised under Th17 conditions have a relative advantage in
supporting antigen specific antibody production.
In addition to the response of the transferred transgenic B cells,
the production of antibodies against OVA by endogenous host B
cells allowed the evaluation of the relative ability of Th1 and Th17
populations to support isotype switching. Serum samples taken
from mice at days 3, 7 and 10 post immunisation were analysed for
the presence of OVA specific IgG1 (Fig. 3A–C), IgG2c (Fig. 3D–F)
and total IgE levels (Fig. 3G–I). IgE antibodies were not detectable
in either Th1 or Th17 recipient mice immunised with OVA-
HEL/CFA (Fig. 3G–I). Prominent differences were noted in the
OVA specific IgG response. Animals that have received cells
polarised under Th17 conditions exhibited significantly higher
OVA specific IgG1 titres from as early as day 7 compared with
animals receiving cells polarised under Th1 conditions (Fig. 3E).
This difference was still evident at day 10 (Fig. 3F). By contrast,
recipients of the Th1 polarised cells displayed significantly higher
titres of anti-OVA-IgG2c antibodies in response to immunisation
compared with recipients of Th17 polarised cells. This was
observed from day 7 and was still evident at the last time point
investigated (day 10; Fig. 3G–I). Only at day 10 could anti-OVA
IgG2c antibodies be detected in Th17 recipients (Fig. 3I), albeit at
levels much lower than Th1 recipients. We also investigated
endogenous anti-OVA-IgMb antibodies, which did not differ
between groups at the time points investigated (data not shown).
These results show that T cells polarised under Th17 conditions
promoted a predominantly IgG1 response, whereas the Th1
polarised population induced high IgG2c antibody levels.
Cells Polarised Under Th17 Cells Persist Longer and in
Higher Numbers in the Draining LNs Compared to their
Th1 Counterparts
The differences in the magnitude of antibody responses
supported by the two T cell populations could have been
attributed to differences in their in vivo expansion. To investigate
this, dLNs were removed from the recipients at days 3, 7 and 10
post-immunisation and the transgenic T cells populations analysed
by flow cytometry (Fig. 4A). As expected, in unimmunised mice
that had received either Th1 or Th17 populations there was no
transgenic T cell expansion, and cells were almost undetectable by
The Role of Th17 Cells in B Cell Responses
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Figure 1. Cells polarised under Th17 conditions have a relative advantage in inducing antigen specific B cells responses compared
to the Th1 population. The number (A) and percentage (B) of GC B cells in dLNs was assessed by flow cytometry 3, 7 and 10 days post-
immunisation. GC B cells were considered B220+cells co-expressing GL-7 and FAS. In addition the number (C) and proportion (B) of HEL-specific
transgenic B cells in dLNs was analysed by flow cytometry, recognised as B220+IgMa+. Results from PBS injected mice from each time point were
averaged and presented as day 0. *: Th1/HEL-OVA vs. Th17/HEL-OVA, # Th1/PBS vs. Th1/HEL-OVA. Data represent mean 6SEM.#,*p,0.05,
##,**p,0.01, ###,***p,0.001 (n = 3). Similar results were obtained in one additional experiment.
doi:10.1371/journal.pone.0049715.g001
Figure 2. Th17 population induces higher titres of anti-HEL antibodies. Serum was taken from the animals and was assessed for the
presence of HEL-specific IgMa antibodies at day 3(A), 7(B) and 10(C). *: Th1/HEL-OVA vs. Th17/HEL-OVA. Data represent mean 6SEM. *p,0.05,
**p,0.01, ***p,0.001 (n = 3). Similar results were obtained in one additional experiment.
doi:10.1371/journal.pone.0049715.g002
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day 10 (Fig. 4B and C) after transfer. Immunisation induced
expansion of both populations, with greater levels being observed
by cells polarised under Th17 conditions (Fig. 4B and C). Cells
polarised under Th1 conditions accumulated in the dLNs, where
their numbers peaked between day 3 and day 7, and reduced to
levels of unimmunised mice by day 10. By contrast, cells polarised
under Th17 conditions accumulated in the dLNs and persisted at
this site in high numbers even up to the last time point investigated
(day 10) (Fig. 4B and C). The persistence of Th17 compared with
Th1 cells was also evident in spleen (Fig S4A and B) and therefore
not restricted to dLN.
A characteristic of in vitro polarised Th17 cells is their
phenotypic instability [24,25]. Therefore, to determine the
phenotype of the transferred populations, cells from the dLNs
were stimulated with PMA and ionomycin, to induce synchronous
cytokine production and the ability of the transgenic T cells to
produce IL-17 or/and IFNc was assessed by flow cytometry
(Fig. 4D and E). In immunised and unimmunised animals, the
transferred Th1 population exhibited a reduction in its ability to
produce IFNc (Fig. 4E), with no increase IL-17 production
(Fig. 4D). The Th17 transferred population in both immunised
and unimmunised mice experienced a much sharper decrease in
the percentage of IL-17+transgenic T cells, with an 83% reduction
by day 3 (Fig. 4C). The proportion of IFNc-producing transgenic
T cells was not affected by the transfer and remained relatively low
(Fig. 4E). Interestingly, in unimmunised Th17 recipient mice the
percentage of IFNc producing tg T cells increased by day 10 to
similar levels as Th1 recipients, however this was not evident in the
immunised mice (4D). Previous studies have suggested that Th17
cells can transform into Th1 effector cells [24], however our data
suggest this does not occur using the polarisation and immunisa-
tion schedule described here.
We also investigated by flow cytometry the expression of the
signature transcription factors for Th17 and Th1 cells, T-bet and
RORct, in the transferred populations seven days post-immunisa-
tion (Fig S4C). This analysis, confirmed maintenance of the
phenotype of the transferred populations, with cells polarised
under Th1 conditions expressing higher levels of T-bet, whereas
their Th17 counterparts expressed higher levels of RORct.
Cells Polarised Under Th17 Conditions Display Enhanced
Viability Compared with their Th1 Counterparts
The greater expansion and persistence of Th17 polarised cells
may be explained by enhanced viability. The viability of Th1 or
Figure 3. The antibody profile induced by the Th1 and Th17 population is different. As MD4 B cells does not class switch the IgG profile of
the OVA specific response was assessed by ELISA. Serum was analysed for the presence of IgG1 (A–C) and IgG2c (D–F) anti-OVA antibodies at days 3,
7 and 10. Furthermore the levels of total IgE levels in the serum of the recipient mice were assessed at the same time points (G–I). *: Th1/HEL-OVA vs.
Th17/HEL-OVA. Data represent mean 6SEM.*p,0.05, **p,0.01, ***p,0.001 (n = 3). Similar results were obtained in one additional experiment.
doi:10.1371/journal.pone.0049715.g003
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Th17 polarised transgenic cells was investigated upon restimula-
tion with antigen pulsed and/or LPS activated bone marrow DC
after 24 and 48 hours (Fig. 5A and C respectively). In the absence
of antigen, cells polarised under Th17 conditions displayed
Figure 4. Differential expansion of Th1 and Th17 populations after adoptive transfer. Th1 or Th17 recipient mice were immunised with
HEL-OVA in CFA or PBS and the expansion of transgenic T cells and their ability to produce IL-17 and IFNc was analysed by FACS. Representative
FACS plots demonstrating gating strategy are demonstrated (A). Collective data demonstrating the percentage (B) and number of (C) of transgenic T
cells at days 3, 7 and 10 post-immunisation amongst draining lymph node cells was assessed by flow cytometry, based on the expression of CD4 and
the clonotypic TcR recognised by the KJ1.26 antibody (A). Unimmunised controls from each time point were averaged and represented as day 0. At
the same days cells from the dLNs were stimulated with PMA and ionomycin and the expression of IL-17 (D) and IFNc (E) by the transferred transgenic
T cells was assessed by flow cytometry. Day 0 represents the proportion of IL-17 or IFNc population in the transferred polarised populations. Grey line
represents Th17 immunised recipients, grey dotted line unimmunised Th17 recipients, black line Th1 immunised recipients and black dotted line Th1
unimmunised recipients. Data represent mean 6SEM. *: Th1/HEL-OVA vs. Th17/HEL-OVA, *p,0.05, **p,0.01, ***p,0.001 (n = 3). Similar results were
obtained in two additional experiments.
doi:10.1371/journal.pone.0049715.g004
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enhanced viability by annexin V/PI staining compared with their
Th1 counterparts. Similarly, in the presence of antigen, cells
polarised under Th17 conditions displayed greater viability
compared with the Th1 population, especially at 48 hrs (Fig. 5C).
In both Th1 and Th17 populations the presence of antigen
resulted in a significant reduction in the percentage of viable cells,
suggesting the decrease in viability may be due to activation-
induced cell death (AICD) (Fig. 5A and C). The increased survival
of Th17 polarised cells is in agreement with a reduced rate of
apoptosis compared with Th1 polarised cells as revealed by
annexin V staining, a phenomenon evident in all conditions and
time-points investigated (Fig. 5B and D). Furthermore, CFSE-
dilution data (Fig S5) demonstrate that there is no difference in
proliferation between the two populations (% of cells that diluted
CFSE after OVA323–339 restimulation: Th1 27%, Th17 23%),
which suggests that differences are due to viability and not to
increased proliferation of the Th17 population. These data
demonstrate that cells polarised under Th17 conditions are more
viable than Th1 polarised cells.
Th17 Polarised Population Expresses Higher Levels of
ICOS Compared to the Th1 Population
An important requirement of T cell-dependent B cell responses
is the migration of activated antigen-specific T cell to the follicular
region to allow interactions with cognate B cells. It has been
reported that this is mediated by the down-regulation of the
chemokine receptor CCR7 and concomitant up-regulation of
CXCR5. In order to assess follicular migration and provision of
co-stimulatory signals by the transferred Th1 and Th17 polarised
populations, the expression of CXCR5 and ICOS was investigated
at days 3, 7 and 10 post-immunisation (Fig. 6A–C). The
proportion of ICOS+CXCR5+transgenic T cells was similar in
both immunised and unimmunised, Th1 or Th17 recipients
(Fig. 6B). This indicated that cells activated under either a Th1 or
Th17 polarising environment are conditioned for follicular
Figure 5. Cells polarised under Th17 conditions are more viable than their Th1 counterparts. MACS sorted CD4+T cells from DO11.10
mice were first polarised towards a Th1 (grey bars) or Th17 (black bars) phenotype and then cultured in the absence of any stimulus or with bone
marrow-derived DCs, unpulsed or pulsed with OVA323–339, or OVA323–339 and LPS. Viability of transgenic and apoptosis levels of T cells was assessed at
two time-points, 24 hrs (A–B) or 48 hrs (C–D) by PI and annexin V staining by flow cytometry. Lymphocytes were identified based on the FSC and SSC
profile and transgenic T cells based on KJ1.26 staining and CD4 expression. Live cells were considered as annexin V and PI negative, whereas
apoptotic cells were considered as annexin V positive. Data represent mean 6SEM.*p,0.05, **p,0.01, ***p,0.001 (n = 3).
doi:10.1371/journal.pone.0049715.g005
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migration. Due to differences in clonal expansion, the number of
transgenic ICOS+CXCR5+T cells was significantly higher in
immunised mice (Fig. 6B and C). Notably, in the Th1 recipients
the number of transgenic T cells that co-expressed ICOS and
CXCR5 peaked at day 3 and declined to unimmunised levels by
day 10. On the other hand, in Th17 recipient mice the number of
transgenic cells with a TFH phenotype increased throughout the
experiment and was significantly higher than in the Th1
population at both days 7 and 10 (Fig. 6C). In order to quantify
the levels of expression of CXCR5 and ICOS by the transgenic T
cells the mean fluorescence intensity (MFI) for these markers was
calculated. Transgenic T cells in unimmunised mice expressed
significantly lower levels of ICOS compared with their immunised
counterparts at all-time points (Fig. 6D and E). Cells polarised
under Th17 conditions expressed significantly higher levels of
ICOS compared with Th1 polarised cells at days 7 and 10,
suggesting a greater capacity to provide costimulatory help at these
time points (Fig. 6E).
While CXCR5 and ICOS have been used extensively as
markers of TFH cells, recent reports [26] suggest that differential
levels of expression of CXCR5 and PD-1 can subdivide this
population into TFH and central memory precursors, with co-
expression of PD-1 and high levels of CXCR5 defining TFH cells.
Thus we investigated the presence of transgenic T cells with this
phenotype 7 days post-immunisation. Using flow cytometry, we
could detect CXCR5high PD-1+transgenic T cells in the dLNs in
all immunised recipients, however mice that received Th17 cells
had a higher percentage of TFH-like transgenic T cells compared
with their Th1 counterparts (Fig S6). We also investigated the
expression of the TFH transcription factor Bcl-6 by flow
cytometry. In accordance with our previous data, cells polarised
under Th17 conditions expressed the highest percentage of Bcl-6
compared with Th1 polarised cells seven days post-challenge (Fig
S6). Collectively, this data suggest that cells polarised under Th17
conditions have a greater potential to acquire a phenotype that
would support B cell responses.
Cells Polarised Under Th17 Conditions Persist Longer in
the B Cell Follicle Compared with the Th1 Population
As T cell migration to the follicle is required for provision of B
cell help we investigated the anatomical localisation of Th1 and
Th17 transgenic T cells in the LN at days 3, 7 and 10 post-
immunisation (Fig S1). There were no differences between the
Th1 and Th17 populations in respect to follicular localisation
(Fig. 7A–C). On day 3, both Th1 and Th17 populations increased
their follicular localisation in response to immunisation (Fig. 7A),
suggesting that recruitment to the follicular area occurs rapidly
and differences observed after that point are due to the greater
number of antigen specific T cells in the dLNs of immunised mice
(Fig. 7A–C). On the other hand, the percentage of the total
transgenic T cells per section that resided in the follicle was higher
in the immunised mice compared to the unimmunised controls at
all-time points investigated (Fig. 7D–F). Furthermore, the number
of transgenic cells per unit of follicular area was significantly
increased in immunised groups (Fig. 7G–I). Importantly, in Th17
recipients this was observed even at day 10, unlike Th1 recipients,
which were at unimmunised levels by this time point (Fig. 7I). This
suggests that cells polarised under Th17 conditions persist in the
follicular area for longer compared with their Th1 counterparts.
Th17 Cells are Absent from Germinal Centres
The location of the T-B cell interaction is an important factor in
determining immunological outcome. For example, early T-B cell
interactions in the follicular border have been linked to low affinity
antibody producing plasmablasts [27], whereas interactions in the
GC are more important for the differentiation of B cells into high
affinity plasma cells and memory cells [28]. Therefore, we
analysed in situ the expression of the Th17 specific transcription
factor RORc to determine the location of Th17 cells in relation to
their cognate B cells as the humoral immune response developed.
RORc transgenic T cells could be detected only in Th17
recipients at each time point investigated (Fig. 8 and data not
shown). Transgenic B cells could be detected in both Th1 and
Th17 recipients. After day 7 the transgenic B cells formed large
aggregates typical of GC. RORc-expressing transgenic T cells
could be detected in close proximity to cognate B cells at day 3 and
7 post immunisation, but not at day 10 (Fig. 8A, B, D and E).
Interestingly, this could only be detected early in the developing
humoral immune response and outside the GC-like structures
(Fig. 8F–I). Even though transgenic T cells could be detected in
these clusters, these never expressed RORc (Fig. 8F–I). We
confirmed that Th17 cells do not reside in GC by staining for them
using peanut agglutinin (PNA). Transgenic Th17 cells could be
detected around GCs, but not in them (Fig. 9).This suggests that
Th17 are probably more important early in the follicular events
that precede the GC reaction or for events that do not require
GCs.
Discussion
Currently, Th17 cells are considered to be pro-inflammatory
effectors that cause tissue inflammation through the production of
cytokines [29–32], with few studies investigating their role in
humoral immune responses [12,13]. Evaluation of the ability of
Th17 cells to support B cell responses is important as in many of
the conditions in which Th17 cells are involved, antibodies also
play an important role [33]. Thus understanding and modulating
Th17 function could be used to promote protective humoral
immunity or alternatively to regulate autoimmune antibody
production. In the current study, we have demonstrated that cells
polarised under Th17 conditions have a relative advantage,
compared with Th1 polarised cells, in providing cognate B cell
help, resulting in greater antibody production. Furthermore, the
two cell populations induced the production of different antibody
isotypes by B cells, with the Th17 population inducing mainly
IgG1, whereas the Th1 population induced higher titres of IgG2c.
The greater ability of the Th17 population to support antibody
production could be attributed to their higher clonal expansion,
persistence in the B cell follicle and/or expression of ICOS
compared with their Th1 counterparts. More importantly, in
draining lymph nodes we could identify Th17 cells in close
proximity to antigen specific B cells soon after antigen challenge,
indicating cognate recognition. However, later in the response
Th17 cells were absent from GCs, suggesting that other Th cells
support this phase of the response. These data collectively
demonstrate that Th17 polarised populations can induce a quan-
titatively and qualitatively distinct humoral immune response from
that supported by cells polarised under Th1 conditions, which
could be potentially useful for the development of vaccines against
pathogens such as fungi.
The greater ability of cells polarised under Th17 conditions,
compared with their Th1 counterparts in supporting B cell
responses is evident through their greater induction of GC B cells,
higher expansion of cognate B cells and antibody production by
these cells. The difference between the two populations is not
limited to the magnitude of antibody response but also extends to
its character. In mice that received cells polarised under Th17
conditions, the IgG response was characterized by the IgG1
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Figure 6. Cells polarised under Th17 conditions have a relative advantage in acquiring a follicular helper phenotype compared to
their Th1 counterparts. The ability of transgenic T cells to acquire a potential to migrate into the B cell follicle and support B cell responses was
analysed by the expression of CXCR5 and ICOS by flow cytometry at days 3, 7 and 10 post-immunisation (A). Lymphocytes were identified based on
the FSC and SSC profile and transgenic T cells based on KJ1.26 staining and CD4 expression. The percentage (B) and number (C) of transgenic T cells
that co-express ICOS and CXCR5 at days 3,7 and 10 are presented. Results from PBS injected mice from each time point were averaged and presented
as day 0. D and E) Mean fluorescent intensity of CXCR5 (D) and ICOS (E) expressed on CD4+KJ1.26+transgenic T cell populations. Data represent mean
6SEM.*p,0.05, **p,0.01, ***p,0.001 (n = 3). Similar results were obtained in one additional experiment.
doi:10.1371/journal.pone.0049715.g006
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isotype and very low levels of IgG2c, whereas Th1 recipients by
IgG2c. The IgG2c (equivalent of IgG2a in BALB/c mice) profile
of the Th1 response is not a surprise as the role of IFNc in IgG2a
class switching is well established [9,10,34]. Our findings agree
with a recent report which demonstrated that the antibody class
profile induced by Th17 polarised populations is characterised
mainly by IgG1, secondly by IgG2b and low levels of IgG2a
antibodies [13]. The absence of IgE antibodies from the Th17
population recipients suggests Th2 cells are not involved in the
humoral response and also fits with a proposed regulatory role for
Th17 cells in IgE production as shown in patients with Job’s
syndrome that have reduced Th17 responses and are characterised
by hyper-IgE [35]. The difference in the antibody profile induced
by the two populations could reflect their ability to provide
protective immunity against different types of pathogens. For
example, the lower levels of IgG2c antibodies in the Th17
recipients may suggest reduced involvement of complement
mediated clearance of pathogens, compared to Th1 recipients.
This, however, needs to be confirmed using in vivo models of
infection that preferentially induce or require Th1 or Th17
responses for resolution.
One possible explanation for the greater ability of cells polarised
under Th17 conditions to support B cell responses is their greater
clonal expansion and persistence in the dLN compared with their
Th1 counterparts. This could be attributed to the greater viability
of the Th17 population. Indeed, reports suggest that Th17 cells are
more resistant to AICD than Th1 cells, a phenomenon possibly
mediated by a reduced expression of FasL by Th17 polarised
populations [36]. Furthermore, there is a documented role for
IFNc in driving AICD of effector T cells [37,38]_ENREF_31,
suggesting that this cytokine could mediate increased cell death in
the Th1 polarised cells. However, differential distribution of the
two populations in the tissues could also account for the observed
differences. A recent study suggests that Th17 polarised cells are
not as efficient as Th1 cells at migrating to non-lymphoid tissues,
due to a reduced expression of the chemokine receptors CCR5
and CXCR3 [39]. This difference in the number of transgenic T
cells in the LN could have profound effects in the humoral
immune response. Indeed, dynamic imaging studies using
Figure 7. Relative ability of Th1 and Th17 populations to localise in the follicle. On days 3 (A), 7(B) and 10 (C) post-immunisation, the
relative ability of the transgenic T cells to localise in the follicular area was quantified in situ by immunofluorescence staining using the VolocityH
software as described in materials and methods and Fig S1. The percentage of the total transgenic T cells of the section that reside in the follicle (D–F)
and the number of transgenic T cells per unit area of follicle (G–H) in the same time points are also presented. At least three sections were analysed
from each animal and each point represents the mean of that. *p,0.05, **p,0.01, ***p,0.001 (n = 3). Similar results were obtained in one additional
experiment.
doi:10.1371/journal.pone.0049715.g007
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multiphoton microscopy and antigen targeting to B cells revealed
that T cell help is the limiting factor for GC intrazonal migration
and B cell clonal expansion [40,41]. It is therefore possible that the
higher numbers of transgenic T cells in the lymphoid compart-
ment of Th17 recipient mice increases the availability of T cell
help to B cells both before and after the formation of the GC
resulting in more robust antibody responses. Apart from the higher
numbers, we demonstrate that the cells polarised under Th17
conditions also expresses higher ICOS levels compared with the
Th1 polarised population. ICOS is a CD28-like molecule which is
crucial for T cell dependent antibody responses and is highly
expressed by TFH cells [42,43]. Absence of this molecule leads to
severe defects in the GC reaction, whereas over-expression is
linked to autoimmune syndromes such as SLE [44–47]. It is
therefore possible that a combination of high number and a higher
ability to provide costimulation leads to a more robust B cells
response in Th17 population recipients.
The spatiotemporal characteristics of the T-B cell interaction
are known to influence the outcome of the B cell response. For
example, early interactions in the T-B cell border could lead to the
development of GCs or early plasma-blasts and memory B cells
that have not undergone class switching [6]. Interaction in the GC
will lead to isotype switching, affinity maturation and generation of
memory B cells [6]. We demonstrated, for the first time to our
knowledge, RORc expressing Th17 cells localising in close
proximity to cognate B cells. However, this was evident only
early in the developing response and never in GCs, suggesting that
Th17 cells participate only in extra-germinal centre B cell
Figure 8. Th17 cells interact with cognate B cells. At days 3, 7 and 10 post immunisation dLNs were snapped frozen and were analysed for the
presence of transgenic Th17 cells by the co-expression of the clonotypic DO11.10 TcR (PURPLE) and RORct (GREEN). In addition transgenic B cells
were detected by staining against IgMa (RED). Representative pictures of dLN sections of: A and B) Th17 recipients 3 days post immunisation C) Th1
recipients 3 days post immunisation D and E) Th17 recipients 7 days post immunisation F) GC-like structures in Th17 recipient 7 days post
immunisation G) GC-like structures in Th1 recipient 7 days post immunisation H) GC-like structures in Th17 recipient 10 days post immunisation I) GC-
like structure in Th1 recipient 10 days post immunisation. Microscope: Carl Zeiss LSM510 META Confocal, Objectives: B) Zeiss planapochromat 406/1
NA water objective; A, C–I) Zeiss PH 256/0.85 NA water objective. Images were acquired using Zeiss LSM510 operating software and off-line image
analysis (contrast enhancement and noise removal) were performed using VolocityH software. At least 3 random sections were imaged per mice and
at least 4 pictures were acquired per section. Similar results were obtained in one additional experiment.
doi:10.1371/journal.pone.0049715.g008
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responses. Our data contradict previous reports in BXD2 mice in
which IL-17 producing CD4 T cells were identified in germinal
centres [12]. This data however may represent a pathological
phenomenon related to autoimmune phenotype of the mouse
strain and not a normal humoral immune response. As in our
studies we did not use purified Th17 T cells, we cannot
discriminate the relative importance of Th17 vs. non-Th17 cells
in the provision of B cell help. This would require Th17 reporter
mice, such as the RORc-EGFP mice, that would allow both intra-
vital imaging of the Th17-B cell cognate interaction and fate
mapping of the antigen-specific T cells as the GC reaction
develops. Indeed, from our studies we cannot exclude that Th17
cells interacting with cognate B cells do not eventually down-
regulate RORct and express markers such as Bcl-6, becoming
TFH cells. Indeed, our data demonstrate that cells polarised under
Th17 conditions upregulate TFH markers such as Bcl-6, ICOS,
PD-1 and CXCR5 to a greater extent than the Th1 population
(Fig S6). However, it remains unclear whether this is due to
transformation of Th17 effector cells to TFH or to their de novo
generation from unpolarised cells. Recent reports have suggested
that the presence of IL-6 and IL-21 can lead to in vitro generated
TFH cells [48]. It therefore possible that IL-6 present in the Th17
cultures, conditions cells towards a TFH-like phenotype. In fact,
a high percentage of the Th17 cells produced IL-21, a character-
istic cytokine for both Th17 and TFH cells.
On the other hand, our data suggest that Th17 effector cells
could co-ordinate early B cell responses, such as the formation of
early plasma blasts until the germinal centre reaction is
established, which is probably coordinated by other Th subtypes
like the Bcl-6 expressing TFH cells.
In conclusion, we demonstrate that cells polarised under Th17
conditions induce a quantitatively and qualitatively different
humoral immune response compared with Th1 cells, a phenom-
enon that should be taken into consideration especially in adjuvant
development for pathogens that have been linked to Th17 cells,
such as fungi.
Supporting Information
Figure S1 Analysis of localisation of transgenic T cells
in the dLNs. A) Tile scan images of dLN sections acquired by
confocal microscopy were analysed using VolocityH software.
Areas of interest were drawn around the borders of the section (ii)
or the B cell follicle based on B220 expression (GREEN) (iv),
which allowed the calculation of the respective surfaces. The
number of transgenic T cells was calculated based on the intensity
of the KJ1.26 staining (RED). (iii and v) Objects smaller than
30 mm and larger than 300 mm were excluded. B) The proportion
of transgenic T cells that reside in the follicle was normalized to
the number of KJ1.26+cells in the section and the surface of the
section and follicle. Microscope: Carl Zeiss LSM510 META
Confocal, Objectives: Zeiss PH 106/0.3NA air objective. Images
were acquired using Zeiss LSM510 operating software and off-line
image analysis (contrast enhancement and noise removal) was
Figure 9. Antigen-specific Th17 cells cannot be located in the germinal centres. At days 7 (A) and 10 (B) post immunisation dLNs of Th17
recipient mice were snap frozen and were stained for PNA (BLUE), IgM (YELLOW), RORc (GREEN), DO11.10 TcR (RED) to identify germinal centre, B cell
follicles, and Th17 trasgenic T cells respectively. Microscope: Carl Zeiss LSM510 META Confocal, Objectives: Zeiss PH 406/1.3NA air objective. Images
were acquired using Zeiss LSM510 operating software and off-line image analysis (contrast enhancement and noise removal) was performed using
VolocityH software. Three random sections per animal were used and at least 3 pictures per section were taken. Similar results were obtained in one
additional experiment.
doi:10.1371/journal.pone.0049715.g009
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performed using VolocityH software. Three random sections per
animal were used.
(TIF)
Figure S2 Phenotype of transferred T and B cells.
Representative plots of intracellular staining for IL-17, IFNc (A)
and IL-21 (B) of polarised Th1 or Th17 DO11.10 cells that were
used for adoptive transfers was performed before transfer into
IgHb mice. B) The proportion of transgenic B cells that recognise
HEL was assessed by their ability to bind biotinylated-HEL.
Biotinylated-BSA was used as a negative control.
(TIF)
Figure S3 Ability of transferred T cells to support
cognate B cell expansion and germinal centre formation.
A) Example plots demonstrating identification of transgenic B cells
by flow cytometry in the dLNs seven days post-immunisation.
Lymphocytes were identified based on the FSC and SSC and
transgenic B cells were identified as lymphocytes co-expressing
B220 and IgMa. B) Example flow cytometry plots of GC B cell
staining in the dLNs 3,7 and 10 days post immunisation.
(TIF)
Figure S4 Expansion of transgenic T cell in spleen and
phenotype of transferred population in dLNs. A and B)
Collective data demonstrating the percentage (A) and number of
(B) of transgenic T cells at days 3, 7 and 10 post-immunisation
amongst spleen cells was assessed by flow cytometry, based on the
expression of CD4 and the clonotypic TcR recognised by the
KJ1.26 antibody. The grey line represents Th17 immunised
recipients, grey dotted line unimmunised Th17 recipients, black
line Th1 immunised recipients and black dotted line Th1
unimmunised recipients. C) Representative flow cytometry data
demonstrating expression of T-bet (top panel) or RORct (lower
panel) by the transgenic T cells 7 days post-immunisation. Data
represent mean 6SEM.*p,0.05, **p,0.01, ***p,0.001 (n = 3).
(TIF)
Figure S5 Ability of Th1 and Th17 polarised population
to proliferate after in-vitro re-stimulation. MACS sorted
CD4+T cells from DO11.10 mice were first polarised towards
a Th1 or Th17 phenotype, rested for 24 hrs and labelled with
CFSE. Cells were restimulated with OVA323–339 in the presence of
mitomycin C treated splenocytes for 48 hrs and their relative
ability to proliferate was assessed by analysis of CFSE dilution.
The figure demonstrates a representative flow cytometry plot of
CFSE staining of transgenic T cells.
(TIF)
Figure S6 Expression of TFH markers by the trans-
ferred T cell populations. A) Example flow cytometry plots of
PD-1 and CXCR5 expression by CD4+KJ1.26+transgenic T cells
from dLNs 7 days post immunisation. B) Example flow cytometry
plots of Bcl-6 levels on CD4+KJ1.26+transgenic T cells from dLNs
7 days post immunisation. In this figure collective flow cytometry
data of PD-1+CXCR5high (C) and Bcl-6+transgenic T cells are also
demonstrated. Data represent mean 6SEM.*p,0.05, **p,0.01,
***p,0.001 (n = 4).
(TIF)
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